LFWD
Lifeward Ltd.NASDAQHealthcare$6.86-0.44%ClosedMarket Cap: $10.5M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.21
P/S
0.47
EV/EBITDA
-0.60
DCF Value
$-276.92
FCF Yield
-161.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
38.3%
Operating Margin
-76.7%
Net Margin
-90.4%
ROE
-145.5%
ROA
-87.0%
ROIC
-149.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $5.1M | 21.4% | $-2.3M | $-5.3M | $-3.60 | — |
| FY 2025 | $22.0M | 38.2% | $-16.9M | $-19.9M | $-17.16 | — |
| Q3 2025 | $6.2M | 43.7% | $-3.1M | $-3.2M | $-2.40 | — |
| Q2 2025 | $5.7M | 43.9% | $-6.6M | $-6.6M | $-6.96 | — |
| Q1 2025 | $5.0M | 42.2% | $-4.9M | $-4.8M | $-5.52 | — |
| Q4 2024 | $7.5M | 24.4% | $-9.5M | $-15.3M | $-20.76 | — |
| FY 2024 | $25.7M | 32.0% | $-19.6M | $-28.9M | $-39.96 | — |
| Q3 2024 | $6.1M | 36.2% | $-3.2M | $-3.1M | $-4.20 | — |
| Q2 2024 | $6.7M | 41.1% | $-4.4M | $-4.3M | $-6.00 | — |
| Q1 2024 | $5.3M | 26.4% | $-6.5M | $-6.3M | $-8.76 | — |
| Q4 2023 | $6.9M | 35.5% | $-6.1M | $-5.6M | $-10.92 | — |
| FY 2023 | $13.9M | 32.1% | $-23.6M | $-22.1M | $-31.08 | — |